Development and validation of common data model-based fracture prediction model using machine learning algorithm.
暂无分享,去创建一个
J. H. Kim | S. Kong | C. S. Shin | Yisak Kim | Kwangsoo Kim | S.-I. Kim
[1] H. Hagino,et al. Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in Japan: a simulation projection model from 2020 to 2040 , 2021, Archives of Osteoporosis.
[2] A. Moayyeri,et al. Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate‐Treated Patients in a Real‐World Setting , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] W. Xia,et al. Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in China: a simulation projection model from 2020 to 2040 , 2021, Archives of Osteoporosis.
[4] Y. Cho,et al. The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database , 2021, Journal of clinical medicine.
[5] Jochen Klenk,et al. Osteoporotic hip fracture prediction from risk factors available in administrative claims data – A machine learning approach , 2020, PloS one.
[6] Sudha Ram,et al. A Novel Fracture Prediction Model Using Machine Learning in a Community‐Based Cohort , 2020, JBMR plus.
[7] J. Kanis,et al. A decade of FRAX: how has it changed the management of osteoporosis? , 2020, Aging Clinical and Experimental Research.
[8] Ross D. Williams,et al. Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network , 2020, PloS one.
[9] Qian Gao,et al. Diabetes mellitus and risk of low-energy fracture: a meta-analysis , 2019, Aging Clinical and Experimental Research.
[10] L. Lix,et al. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study , 2019, Osteoporosis International.
[11] Changhee Lee,et al. DeepHit: A Deep Learning Approach to Survival Analysis With Competing Risks , 2018, AAAI.
[12] P. Vestergaard,et al. Does bone mineral density improve the predictive accuracy of fracture risk assessment? A prospective cohort study in Northern Denmark , 2018, BMJ Open.
[13] J. Compston,et al. Type 2 diabetes mellitus and bone , 2018, Journal of internal medicine.
[14] H. Blain,et al. Osteoporosis and ischemic cardiovascular disease. , 2017, Joint, bone, spine : revue du rhumatisme.
[15] E. Jang,et al. Development of a Korean Fracture Risk Score (KFRS) for Predicting Osteoporotic Fracture Risk: Analysis of Data from the Korean National Health Insurance Service , 2016, PloS one.
[16] W. Gu,et al. Stroke increases the risk of hip fracture: a systematic review and meta-analysis , 2016, Osteoporosis International.
[17] L. Thabane,et al. Comparison between frailty index of deficit accumulation and fracture risk assessment tool (FRAX) in prediction of risk of fractures. , 2015, Bone.
[18] Jianzhong Xu,et al. The Association between Aortic Calcification and Fracture Risk in Postmenopausal Women in China: The Prospective Chongqing Osteoporosis Study , 2014, PloS one.
[19] Nicholette D. Palmer,et al. Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study. , 2014, The Journal of clinical endocrinology and metabolism.
[20] J. Starup-Linde. Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone , 2012, Front. Endocrinol..
[21] Patrick B. Ryan,et al. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases , 2012, J. Biomed. Informatics.
[22] A. LaCroix,et al. Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW) , 2012, Osteoporosis International.
[23] L. Weinehall,et al. Low bone mineral density is associated with increased risk for myocardial infarction in men and women , 2012, Osteoporosis International.
[24] A. LaCroix,et al. Predicting fractures in an international cohort using risk factor algorithms without BMD , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] Y. Ha,et al. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea , 2011, Journal of Bone and Mineral Metabolism.
[26] J. Overhage,et al. Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership , 2010, Annals of Internal Medicine.
[27] Y. Khang,et al. Clinical risk factors for osteoporotic fracture: A population‐based prospective cohort study in Korea , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] D. Kiel,et al. Increased Bone Resorption Is Associated With Increased Risk of Cardiovascular Events in Men: The MINOS Study , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] Carol Coupland,et al. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores , 2009, BMJ : British Medical Journal.
[30] C. Cooper,et al. Excess mortality following hip fracture: a systematic epidemiological review , 2009, Osteoporosis International.
[31] N. D. Nguyen,et al. Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks , 2008, Osteoporosis International.
[32] A. Ho,et al. Ten‐Year Risk of Osteoporotic Fractures in Postmenopausal Chinese Women According to Clinical Risk Factors and BMD T‐Scores: A Prospective Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] E. Binder,et al. Falls in older adults: risk assessment, management and prevention. , 2007, The American journal of medicine.
[34] N. D. Nguyen,et al. Development of a nomogram for individualizing hip fracture risk in men and women , 2007, Osteoporosis International.
[35] Jacques P. Brown,et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women , 2007, Osteoporosis International.
[36] D. Balzi,et al. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. , 2005, American journal of physiology. Endocrinology and metabolism.
[37] R. Komel,et al. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. , 2005, Maturitas.
[38] R. D'Agostino,et al. Presentation of multivariate data for clinical use: The Framingham Study risk score functions , 2004, Statistics in medicine.
[39] C. Tauber,et al. Morbidity and mortality after hip fracture: the impact of operative delay , 2004, Archives of Orthopaedic and Trauma Surgery.
[40] S. Cummings,et al. Clinical use of bone densitometry: scientific review. , 2002, JAMA.
[41] O. Johnell,et al. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures , 1996 .